Published in Obesity and Diabetes Week, May 23rd, 2005
The company discovered a new process to generate immortal cell lines that can be induced to form cells of the beta islets by exposure to certain environmental conditions. The new patent application describes a method of producing and maintaining beta islet progenitor cells as well as about 30 new human beta islet progenitor cell lines.
The new cell lines developed by the company are not derived from human embryonic stem...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week